392 results on '"Nishtala, Prasad S"'
Search Results
2. An overview of pharmacoepidemiology in New Zealand : medical databases, registries and research achievements
3. Antibiotic-Associated Acute Kidney Injury Among Older Adults: A Case-Crossover Study
4. Utility of Big Data to Explore Medication Adherence in Māori and Non-Māori Community-Dwelling Older Adults with Heart Failure in Aotearoa New Zealand: A Cross-sectional Study
5. Application of machine learning approaches in predicting clinical outcomes in older adults – a systematic review and meta-analysis
6. The association between anticholinergic burden and mobility: a systematic review and meta-analyses
7. The Drug Burden Index and Level of Frailty as Determinants of Healthcare Costs in a Cohort of Older Frail Adults in New Zealand
8. Post Hoc Analyses of a Randomized Controlled Trial for the Effect of Pharmacist Deprescribing Intervention on the Anticholinergic Burden in Frail Community-Dwelling Older Adults
9. Assessing the anticholinergic cognitive burden classification of putative anticholinergic drugs using drug properties
10. An Updated Analysis of Psychotropic Medicine Utilisation in Older People in New Zealand from 2005 to 2019
11. Rates of psychotropic medicine prescribing in paediatric populations in Australian general practice from 2000-2016
12. Investigating Variations in Medicine Approvals for Attention-Deficit/Hyperactivity Disorder: A Cross-Country Document Analysis Comparing Drug Labeling.
13. Drug Burden Index is a Modifiable Predictor of 30-Day-Hospitalization in Community-Dwelling Older Adults with Complex Care Needs: Machine Learning Analysis of InterRAI Data
14. Pharmaceutical Care in Australia and New Zealand
15. Predictors of Residential Care Admission in Community-Dwelling Older People With Dementia
16. Risk of antimicrobial-associated organ injury among the older adults: a systematic review and meta-analysis
17. Analysis of the adverse events following the mRNA-1273 COVID-19 vaccine
18. A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS)
19. Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics
20. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities
21. International trends in antipsychotic use: A study in 16 countries, 2005–2014
22. Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database
23. Potentially inappropriate medications in community-dwelling older adults undertaken as a comprehensive geriatric risk assessment
24. Acute renal failure and cardiac arrhythmias associated with remdesivir use in patients with COVID-19 infections: Analysis using the US FDA adverse event reporting system
25. Safety outcomes associated with the Moderna COVID-19 vaccine (mRNA-1273): a literature review
26. Drug Burden and its Association with Falls Among Older Adults in New Zealand: A National Population Cross-Sectional Study
27. ‘Real-world’ haemorrhagic rates for warfarin and dabigatran using population-level data in New Zealand
28. Antiepileptic medicine utilization in older people over a 9-year study period
29. Pharmaceutical Care in Australia and New Zealand
30. Antibiotic utilisation and the impact of antimicrobial resistance action plan on prescribing among older adults in New Zealand between 2005 and 2019
31. Deprescribing anticholinergic and sedative drugs to reduce polypharmacy in frail older adults living in the community: a randomized controlled trial
32. Analysis of the nervous system and gastrointestinal adverse events associated with solifenacin in older adults using the US FDA adverse event reporting system
33. A population-level study examining discontinuation of statins in older people with dementia
34. Development and validation of a Medicines Comorbidity Index for older people
35. Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review
36. Real-world risk of diabetes with antipsychotic use in older New Zealanders: a case-crossover study
37. Application of machine learning approaches in predicting clinical outcomes in older adults – a systematic review and meta-analysis.
38. Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research
39. The association between anticholinergic burden and mobility: A systematic review and meta-analyses
40. Development and validation of a frailty index compatible with three interRAI assessment instruments
41. Antibacterial‐associated acute kidney injury among older adults: A post‐marketing surveillance study using the FDA adverse events reporting system
42. Geographic variation in psychotropic drug utilisation among older people in New Zealand
43. Evaluation of the National Minimum Data Set for Neurological Conditions in Older Adults
44. Associations of Potentially Inappropriate Medicine Use with Fall-Related Hospitalisations and Primary Care Visits in Older New Zealanders: A Population-Level Study Using the Updated 2012 Beers Criteria
45. Analgesic Medicine Utilization in Older People in New Zealand from 2005 to 2013
46. Risk of delirium associated with antimuscarinics in older adults: a case‐time‐control study
47. Antimicrobial-associated organ injury among the elderly: a systematic review and meta-analysis protocol
48. Zopiclone Use and Risk of Fractures in Older People: Population-Based Study
49. Impact of the Pharmacist Medication Review Services on Drug-Related Problems and Potentially Inappropriate Prescribing of Renally Cleared Medications in Residents of Aged Care Facilities
50. Psychotropic Medicine Utilization in Older People in New Zealand from 2005 to 2013
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.